Pharmacokinetics of recombinant human annexin A5 (SY-005) in patients with severe COVID-19
Brent J. Tschirhart(Western University), Qingping Feng(Lawson Health Research Institute), Claudio M. Martin(Western University), Marat Slessarev(Western University), Douglas D. Fraser(Western University), Xiangru Lu(Western University), Aleksandra Leligdowicz(University of California, San Francisco), Bradley L. Urquhart, Aristide Laurel Mokale Kognou(Western University)
Cited by 6
Related Papers
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
|New England Journal of Medicine|1999|5.2k
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
|Clinical Infectious Diseases|2014|1.1k
Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study
|Intensive Care Medicine|2001|984
Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?
|Critical Care Medicine|2001|597